Press releases

Orchard Therapeutics Announces Strategic Alliance with Oxford BioMedica

Orchard Therapeutics announces today that it has entered into a strategic alliance with Oxford BioMedica plc, a world-leading company in gene and cell therapy

Read more

Orchard Therapeutics and UCLA receive $19 million in latest round of funding from California’s stem cell agency

Orchard Therapeutics Limited and researchers from the UCLA Broad Stem Cell Research Center, led by Orchard Scientific Advisory Board member Dr. Donald Kohn have been awarded $19 million by the California Institute for Regenerative Medicine’s governing board (CIRM)

Read more

Dr Andrea Spezzi named one of BioBeat Movers and Shakers in the BioBusiness report - 2016

Dr Andrea Spezzi, CMO, R&D Head and co-founder of Orchard Therapeutics, has been named as one of the women changing the face and future of healthcare in the BioBeat 50 Movers and Shakers in the BioBusiness 2016 report

Read more

Orchard Therapeutics announces the opening of US operations in Foster City, California

Orchard is developing a global platform of ex-vivo autologous gene therapies in serious and life-threatening orphan diseases. In the United States, Orchard has collaborations with the University of California Los Angeles (“UCLA”) and Boston Children’s Hospital, and with leading manufacturing partners specialized in gene and cell therapy

Read more

Orchard Therapeutics announces presentations from UCL/GOSH and UCLA academic collaborators on clinical data in ADA-SCID

Orchard Therapeutics announces presentations from UCL/GOSH and UCLA academic collaborators on clinical data in ADA-SCID using ex-vivo lentiviral gene therapy at September 2016 ESID and ESGCT congresses

Read more